Inhibiting O-GlcNAcylation impacts p38 and Erk1/2 signaling and perturbs cardiomyocyte hypertrophy

The dynamic cycling of O-linked GlcNAc (O-GlcNAc) on and off Ser/Thr residues of intracellular proteins, termed O-GlcNAcylation, is mediated by the conserved enzymes O-GlcNAc transferase (OGT) and O-GlcNAcase. O-GlcNAc cycling is important in homeostatic and stress responses, and its perturbation sensitizes the heart to ischemic and other injuries. Despite considerable progress, many molecular pathways impacted by O-GlcNAcylation in the heart remain unclear. The mitogen-activated protein kinase (MAPK) pathway is a central signaling cascade that coordinates developmental, physiological, and pathological responses in the heart. The developmental or adaptive arm of MAPK signaling is primarily mediated by Erk kinases, while the pathophysiologic arm is mediated by p38 and Jnk kinases. Here, we examine whether O-GlcNAcylation affects MAPK signaling in cardiac myocytes, focusing on Erk1/2 and p38 in basal and hypertrophic conditions induced by phenylephrine. Using metabolic labeling of glycans coupled with alkyne-azide “click” chemistry, we found that Erk1/2 and p38 are O-GlcNAcylated. Supporting the regulation of p38 by O-GlcNAcylation, the OGT inhibitor, OSMI-1, triggers the phosphorylation of p38, an event that involves the NOX2–Ask1–MKK3/6 signaling axis and also the noncanonical activator Tab1. Additionally, OGT inhibition blocks the phenylephrine-induced phosphorylation of Erk1/2. Consistent with perturbed MAPK signaling, OSMI-1–treated cardiomyocytes have a blunted hypertrophic response to phenylephrine, decreased expression of cTnT (key component of the contractile apparatus), and increased expression of maladaptive natriuretic factors Anp and Bnp. Collectively, these studies highlight new roles for O-GlcNAcylation in maintaining a balanced activity of Erk1/2 and p38 MAPKs during hypertrophic growth responses in cardiomyocytes. The dynamic cycling of O-linked GlcNAc (O-GlcNAc) on and off Ser/Thr residues of intracellular proteins, termed O-GlcNAcylation, is mediated by the conserved enzymes O-GlcNAc transferase (OGT) and O-GlcNAcase. O-GlcNAc cycling is important in homeostatic and stress responses, and its perturbation sensitizes the heart to ischemic and other injuries. Despite considerable progress, many molecular pathways impacted by O-GlcNAcylation in the heart remain unclear. The mitogen-activated protein kinase (MAPK) pathway is a central signaling cascade that coordinates developmental, physiological, and pathological responses in the heart. The developmental or adaptive arm of MAPK signaling is primarily mediated by Erk kinases, while the pathophysiologic arm is mediated by p38 and Jnk kinases. Here, we examine whether O-GlcNAcylation affects MAPK signaling in cardiac myocytes, focusing on Erk1/2 and p38 in basal and hypertrophic conditions induced by phenylephrine. Using metabolic labeling of glycans coupled with alkyne-azide “click” chemistry, we found that Erk1/2 and p38 are O-GlcNAcylated. Supporting the regulation of p38 by O-GlcNAcylation, the OGT inhibitor, OSMI-1, triggers the phosphorylation of p38, an event that involves the NOX2–Ask1–MKK3/6 signaling axis and also the noncanonical activator Tab1. Additionally, OGT inhibition blocks the phenylephrine-induced phosphorylation of Erk1/2. Consistent with perturbed MAPK signaling, OSMI-1–treated cardiomyocytes have a blunted hypertrophic response to phenylephrine, decreased expression of cTnT (key component of the contractile apparatus), and increased expression of maladaptive natriuretic factors Anp and Bnp. Collectively, these studies highlight new roles for O-GlcNAcylation in maintaining a balanced activity of Erk1/2 and p38 MAPKs during hypertrophic growth responses in cardiomyocytes. The enzyme O-GlcNAc transferase (OGT) utilizes UDP-GlcNAc as a substrate and covalently links the GlcNAc moiety to Ser/Thr residues of intracellular proteins (1Hart G.W. Housley M.P. Slawson C. Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins.Nature. 2007; 446: 1017-1022Crossref PubMed Scopus (1083) Google Scholar, 2Bond M.R. Hanover J.A. A little sugar goes a long way: the cell biology of O-GlcNAc.J. Cell Biol. 2015; 208: 869-880Crossref PubMed Scopus (383) Google Scholar, 3Levine Z.G. Walker S. The biochemistry of O-GlcNAc transferase: which functions make it essential in mammalian cells?.Annu. Rev. Biochem. 2016; 85: 631-657Crossref PubMed Scopus (114) Google Scholar). The O-GlcNAcase (OGA) catalyzes the opposing reaction, removing O-GlcNAc from proteins (4Toleman C. Paterson A.J. Whisenhunt T.R. Kudlow J.E. Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities.J. Biol. Chem. 2004; 279: 53665-53673Abstract Full Text Full Text PDF PubMed Scopus (167) Google Scholar, 5Gao Y. Wells L. Comer F.I. Parker G.J. Hart G.W. Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain.J. Biol. Chem. 2001; 276: 9838-9845Abstract Full Text Full Text PDF PubMed Scopus (519) Google Scholar). Collectively known as O-GlcNAcylation, this protein modification is reversible, highly dynamic, and positioned at the intersection of homeostatic and stress pathways (6Chatham J.C. Nöt L.G. Fülöp N. Marchase R.B. Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma.Shock. 2008; 29: 431-440Crossref PubMed Scopus (85) Google Scholar, 7Groves J.A. Lee A. Yildirir G. Zachara N.E. Dynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis.Cell Stress Chaperones. 2013; 18: 535-558Crossref PubMed Scopus (96) Google Scholar). Both Ogt and Oga genes, necessary for O-GlcNAc cycling, are essential for mammalian development and survival (8Shafi R. Iyer S.P.N. Ellies L.G. O'Donnell N. Marek K.W. Chui D. et al.The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny.Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 5735-5739Crossref PubMed Scopus (596) Google Scholar, 9Yang Y.R. Song M. Lee H. Jeon Y. Choi E.J. Jang H.J. et al.O-GlcNAcase is essential for embryonic development and maintenance of genomic stability.Aging Cell. 2012; 11: 439-448Crossref PubMed Scopus (163) Google Scholar, 10Keembiyehetty C. Love D.C. Harwood K.R. Gavrilova O. Comly M.E. Hanover J.A. Conditional knock-out reveals a requirement for O-linked N-acetylglucosaminase (O-GlcNAcase) in metabolic homeostasis.J. Biol. Chem. 2015; 290: 7097-7113Abstract Full Text Full Text PDF PubMed Scopus (90) Google Scholar). In the heart and the cardiac myocyte, O-GlcNAc cycling has been shown to play important roles in ischemia-reperfusion injury (11Fülöp N. Zhang Z. Marchase R.B. Chatham J.C. Glucosamine cardioprotection in perfused rat heart associated with increased O-Linked N-acetylglucosamine protein modification and altered p38 activation.Am. J. Physiol. Heart Circ. Physiol. 2007; 292: H2227-H2236Crossref PubMed Scopus (0) Google Scholar, 12Jones S.P. Zachara N.E. Y. A. et by N-acetylglucosamine to cellular 2008; PubMed Scopus Google hypertrophic H. et O-GlcNAc signaling is increased in and heart PubMed Scopus (0) Google Scholar, S. K.R. et Ogt in PubMed Scopus Google Scholar, D. D. O-GlcNAc transferase cardiac and protein kinase during and pathological from Heart Scopus Google Scholar, S. K.R. J.A. et Oga O-GlcNAcylation PubMed Scopus Google and J. J.A. et protein O-GlcNAcylation and the of J. Physiol. Heart Circ. Physiol. 2012; PubMed Scopus (0) Google Scholar, D. M. et the cardiac O-GlcNAcylation enzymes the and of the PubMed Scopus Google Scholar, N. Y. et and O-GlcNAcylation increased in by PubMed Scopus Google and heart M. et β-N-acetylglucosamine transferase is in the Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar, N. et O-GlcNAcylation heart and PubMed Scopus (0) Google Scholar). The that of O-GlcNAcylation a against stress, cardiac S. S.P. O-GlcNAc and the PubMed Scopus Google Scholar, R. C. S. L. O-GlcNAcylation, or during cardiac 2016; PubMed Scopus Google Scholar, Chatham J.C. O-GlcNAcylation and PubMed Scopus Google Scholar, S. J. O-GlcNAcylation and the of PubMed Scopus Google Scholar). it has been that highly dynamic O-GlcNAcylation with phosphorylation to an of regulation of protein G.W. Slawson C. G. O. O-GlcNAcylation and roles in signaling, and Rev. Biochem. PubMed Scopus Google Scholar). studies in the heart and cardiac found that O-GlcNAcylation the of as the kinase L. L. G. A. et and by O-linked 2013; PubMed Scopus Google the protein kinase R. J. L. A. et cardiac by PubMed Scopus Google and the growth J. Zhang G. et of biosynthesis in the heart triggers pathological cardiac 11: PubMed Scopus (0) Google Scholar). The mitogen-activated protein are a conserved of an signaling cascade by and factors on J. of cardiac by intracellular Rev. Cell Biol. PubMed Scopus Google Scholar, Y. protein in heart development and 2007; PubMed Scopus Google Scholar). The of MAPK signaling, and have and in cardiac myocytes, to and cell Erk1/2 and survival et signaling pathway from ischemic injury in 2004; PubMed Scopus (0) Google Scholar, M. A.J. phosphorylation at and increased in the heart Biol. Chem. 2008; Full Text Full Text PDF PubMed Scopus Google Scholar, A. S. J. et inhibition of cardiac and heart has on in Natl. Acad. Sci. U. S. A. 2007; PubMed Scopus (0) Google and are also important in and of T.R. R. et al.The signaling pathway cardiac in J. 2000; PubMed Google Scholar, J.C. the hypertrophic growth of cardiomyocytes Cell Biol. PubMed Scopus Google Scholar, M. as of cardiac 2015; PubMed Google Scholar, R. A.J. M. cardiac by 2016; PubMed Scopus Google Scholar). The the protein to the which and of Erk1/2 G.W. signaling pathways that cardiac Rev. Physiol. 2001; PubMed Scopus Google Scholar). of Erk1/2 are the and M. and of the MAPKs and the protein Biol. Rev. PubMed Scopus Google which are that the to the also to as and S. H. et of is in of the gene in cardiac Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar, G.J. J. M. of by pathway is necessary for gene during cardiac Cell. 2000; Full Text PDF PubMed Scopus Google Scholar, J. J. J. of and MAPK pathways by and the of Natl. Acad. Sci. U. S. A. 2008; PubMed Scopus Google Scholar, J. M.E. of the pathway to gene by a growth PubMed Google Scholar, A. and are for the and phosphorylation of and in Cell. Biol. PubMed Scopus Google Scholar). Erk1/2 are to associated with adaptive responses, p38 signaling are associated with maladaptive and cardiac M. D. G. L. J. et kinase in cardiomyocytes and in PubMed Scopus Google Scholar, M. et p38 MAPK in 2013; PubMed Scopus Google Scholar, J.C. S. et inhibition of p38 MAPK hypertrophic of PubMed Scopus Google Scholar). the phosphorylation of p38 that and proteins which in the of and p38 M. from to mitogen-activated protein PubMed Scopus Google Scholar, J. G. Y. H. regulation of mitogen-activated protein kinase kinase and in Biol. Chem. 2001; 276: Full Text Full Text PDF PubMed Scopus Google Scholar, The and of a of hypertrophic signaling PubMed Scopus Google Scholar). The of p38 and in as the protein the and the factors and M. from to mitogen-activated protein PubMed Scopus Google Scholar, A. and functions of p38 MAPK J. PubMed Scopus Google Scholar). a O-GlcNAcylation and phosphorylation on factors Comer F.I. Hart G.W. Dynamic O-glycosylation and of nucleocytoplasmic proteins: of a known of in is by Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, H. H. Zhang M. et N-acetylglucosamine modification on protein during Biol. Chem. Full Text Full Text PDF PubMed Scopus (0) Google Scholar, J.E. Dynamic O-GlcNAc modification gene expression and Chem. Biol. 2012; PubMed Scopus Google and L. Zhang S. Y. et of cell associated with phosphorylation and O-GlcNAc 2012; PubMed Scopus Google Scholar, D. C. J. et O-GlcNAcylation affects the of expression and its O-GlcNAc Google Scholar, S. S.P. et modification of proteins Chem. PubMed Scopus Google Scholar). for O-GlcNAcylation on on Erk1/2 and p38, is In the we whether in O-GlcNAcylation basal and MAPK signaling in cardiac that O-GlcNAcylation with the OGT basal p38 phosphorylation at the it blocks Erk1/2 phosphorylation and growth at a found MAPK signaling that for O-GlcNAcylation, Erk1/2 and p38, also and and the and O-GlcNAcylation and MAPK signaling in cardiac myocytes, the for the of O-GlcNAcylation in cardiac and heart rat a cellular to the of the MAPK signaling cascade in cardiac to the increased the phosphorylation of p38, and the the hypertrophic signaling, we and to Erk1/2 and E.J. S. H. A. et of a with activity in of to and 2013; PubMed Scopus Google Scholar, S. S. D. et of p38 mitogen-activated protein kinase in the Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, S.P. H. M. and of of protein kinase J. 2000; PubMed Scopus (0) Google Scholar). growth at of by for shown in and increased and this by the Erk1/2 The p38 while the of the growth The of in the phosphorylation of Erk1/2 this response also by and In the to have an in Erk1/2 phosphorylation In with the p38 we a in p38 by that the phosphorylation of p38 is by a inhibition of p38 its kinase to phosphorylation of p38, inhibition of its activity of the protein kinase by J. PubMed Scopus Google Scholar). the p38 or p38 at the of the kinase its phosphorylation S. Lee J.C. the activity the of p38 mitogen-activated protein PubMed Scopus Google Scholar). the increased p38 phosphorylation with in basal and conditions and A of p38, the protein the inhibition of p38 by the phosphorylation of phosphorylation of by and In and or in phosphorylation of and the expression of cTnT and Anp as of hypertrophic or the cTnT expression and in the other Anp with a pathway Erk1/2 to of Anp S. H. R. H. factors in the and 2004; PubMed Scopus Google Scholar). Collectively, these that Erk1/2 and p38 to the growth response in of we whether p38 and Erk1/2 O-GlcNAcylated. we metabolic labeling in the sugar or are or as of OGT in intracellular protein O-GlcNAcylation M.R. of glycans and 18: PubMed Scopus (0) Google Scholar, N. M.R. proteins metabolic and PubMed Scopus (0) Google Scholar, A. G. A.J. Choi J. et of metabolic with and by an Chem. Biol. PubMed Scopus Google In a of we with or for and protein in with a that it with an a for the Chem. 2015; PubMed Scopus Google Scholar). Using we of the in proteins from in in the of the we with or as and proteins from with and proteins The from the to with the of proteins with this the to for O-GlcNAcylation on MAPKs Erk1/2 and by we found that the Erk1/2 and also its The also with that it is J.E. Dynamic O-GlcNAc modification gene expression and Chem. Biol. 2012; PubMed Scopus Google Scholar). by MAPK signaling, also in the we found that the other MAPK of p38, and its these that in the MAPK signaling pathway are for O-GlcNAcylation in cardiac O-GlcNAcylation in with and OSMI-1, of and J. M. J. C. et that OGT activity in Chem. Biol. 2015; PubMed Scopus Google Scholar, J.E. Y. et O-GlcNAcase that blocks phosphorylation of in Chem. Biol. 2008; PubMed Scopus Google Scholar). with to in protein O-GlcNAcylation, while O-GlcNAcylation by A and Consistent with protein in with and OGT in with and the of O-GlcNAcylation, and induced in protein O-GlcNAcylation and and we whether or altered the of and biosynthesis by in UDP-GlcNAc by or with and in and or OSMI-1–treated with we whether a on for A that the of impacted by and the other which blocks the of GlcNAc induced a in the and we the of and on MAPK phosphorylation with or found that induced a in p38 phosphorylation A and In or in with p38 on Erk1/2 at or in conditions A and p38 phosphorylation increased during an to OSMI-1, by a in phosphorylation phosphorylation increased in phosphorylation and in the phosphorylation of MAPK we found that phosphorylation of increased by this the in OSMI-1–treated and that the of p38 phosphorylation by is a event that the MAPK signaling pathway at a that is from and the of its the p38 to the phosphorylation of and it also at the phosphorylation of the Collectively, these that OGT inhibition p38 phosphorylation and its the that protein O-GlcNAcylation with triggers p38 we other OGT p38 is to and OGT by the UDP-GlcNAc of OGT J.A. J. et of O-GlcNAc transferase Chem. PubMed Scopus Google Scholar). In we a metabolic that is to which functions as a OGT L. et of O-GlcNAc transferase that in decreased O-GlcNAc in Chem. Google Scholar). with induced in protein O-GlcNAcylation and of for OSMI-1, and A and induced in p38 phosphorylation and for OSMI-1, and and that the an of the of shown metabolic labeling with we found that p38 is on p38 we whether p38 that we with with to or also in Using we found of proteins in in that p38 in from and in OSMI-1–treated the that p38 is at and that this by OGT inhibition with we whether in the phosphorylation of are for and which are the of p38 phosphorylation also in we of and to whether the p38 we found that with or decreased phosphorylation of p38 and and and are of in p38 and have been as in cardiac The for its to p38 phosphorylation or with for we that this p38 phosphorylation or the phosphorylation of a of we in p38 and a of it of p38 phosphorylation and phosphorylation we the or in with and whether this p38 p38 phosphorylation in the of and it by the of and we the of this in p38 and it for the of the p38 phosphorylation is or p38 to on other of p38 that of the kinase in its in the cell pathways to the p38 phosphorylation and these with the we to of the kinases. we found that with an induced a in p38 phosphorylation and A in p38 phosphorylation also with and the in p38 phosphorylation by to a in phosphorylation these with that p38 phosphorylation is mediated by that are in by with from to the of in the of cytosolic in cardiomyocytes is the of enzymes on the that from to to Y. H. and in Rev. PubMed Scopus Google Scholar). examine whether are in p38 in we to by gene cytosolic a that from the to the to with and the of In with a in this we found that the phosphorylation of p38 as as the phosphorylation of in OSMI-1–treated we to the of this the phosphorylation of p38 and as a of p38 phosphorylation the In to the of p38 by p38 noncanonical by in cardiac is in by the which p38 from with its A. Zhang J. J. Y. regulation of noncanonical by in PubMed Scopus Google Scholar, H. L. et of mediated by of PubMed Scopus Google Scholar). Additionally, is known to O-GlcNAcylation S. O. A. O-GlcNAcylation of J. 2012; PubMed Scopus Google Scholar). In metabolic labeling with in cardiac myocytes, we found that and that the noncanonical pathway of p38 also in to regulation by we first whether the noncanonical p38 signaling in increased the phosphorylation of and this to the of phosphorylation by and to increased the phosphorylation of p38 and in a that to the of that is an of to inhibition to p38 the of the noncanonical pathway in p38 we in with to a in protein by to in the or of and of decreased the phosphorylation of p38 and as an of p38 phosphorylation in we the of on the on Erk1/2 and p38 phosphorylation of Erk1/2 blunted by the A and In to the phosphorylation of with for increased the phosphorylation of p38 A and the in p38 phosphorylation in to decreased protein of p38 the of to in p38 the phosphorylation of the also in OSMI-1–treated with increased p38 activity A and the other the on basal phosphorylation and also its phosphorylation and the in protein of OGT a we whether the for the increased the protein of OGT and decreased the protein of we whether O-GlcNAcylation with or for by with induced a in cell in and this hypertrophic growth and is with the perturbed Erk1/2 and p38 signaling of that OSMI-1, with associated with that in to its also viability in the molecular the of cTnT and and the of Anp and and A phosphorylation signaling and O-GlcNAcylation has been G.W. Slawson C. G. O. O-GlcNAcylation and roles in signaling, and Rev. Biochem. PubMed Scopus Google Scholar, Z. M. Hart G.W. and phosphorylation in response to Natl. Acad. Sci. U. S. A. 2008; PubMed Scopus Google Scholar). The MAPK signaling cascade is a of growth and it also to cardiac In this we the O-GlcNAcylation and MAPK signaling in cardiac at and during hypertrophic The of the are as the MAPKs Erk1/2 to the hypertrophic growth of cardiac of with from p38, a of Erk1/2 and p38 are as as signaling and of the Erk1/2 and p38 kinases, the OGT and O-GlcNAcylation in cardiac and a of p38 phosphorylation at and to Erk1/2 p38 and the growth of cardiomyocytes. on the of p38 by OSMI-1, that are of a signaling axis that the to and p38, of the noncanonical p38 pathway that the protein and a O-GlcNAcylation of p38 that its it found that cardiac to increased O-GlcNAcylation, associated with increased phosphorylation of Erk1/2 L. M. S. G. O-GlcNAcylation in cardiac and 2013; PubMed Scopus Google Scholar). A O-GlcNAc and Erk1/2 phosphorylation also in and M. Z. Zhang S. et O-GlcNAcylation by cell proteins and 2016; PubMed Scopus Google Scholar, N. Y. L. et of O-GlcNAc with Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). on Erk1/2 phosphorylation during O-GlcNAc a we found that O-GlcNAcylation with basal and Erk1/2 phosphorylation and the is for a with we found the Erk1/2 phosphorylation to blunted in to for A of L. L. J. et al.The human and PubMed Scopus Google for O-GlcNAcylation on Erk1/2 and the In with this we have with metabolic and that of Erk1/2 and are O-GlcNAcylated. the of O-GlcNAcylation on these to Erk1/2 is that O-GlcNAcylation the phosphorylation on of to of Erk1/2 J. J. Y. et O-GlcNAc and expression with PubMed Scopus (0) Google Scholar). of the of Erk1/2 phosphorylation is to play a in the blunted hypertrophic response we Erk1/2 is the signaling MAPK that growth during the other MAPK of p38, we found that a of its phosphorylation and at and and induced the phosphorylation of p38 in and it also an on p38 phosphorylation with O-GlcNAcylation in cardiomyocytes with increased p38 is in with in and it found that O-GlcNAcylation with increased or the phosphorylation of p38 H. C. O-linked β-N-acetylglucosamine p38 MAPK by in J. Physiol. PubMed Scopus Google Scholar, Marchase R.B. O-GlcNAc signaling in Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). studies from to of O-GlcNAc which are to in these it is to make as to for the in these cell for the p38 phosphorylation with O-GlcNAcylation, the first found increased activity of Marchase R.B. O-GlcNAc signaling in Biol. Chem. Full Text Full Text PDF PubMed Scopus Google while the other found for in p38 phosphorylation H. C. O-linked β-N-acetylglucosamine p38 MAPK by in J. Physiol. PubMed Scopus Google Scholar). In with the of the is O-GlcNAcylation p38 we found that the pathway to p38 of p38 phosphorylation by in the of has been in cardiac and et regulation of cardiac kinase protein and cardiac to PubMed Scopus (0) Google Scholar). of are the and of the of phosphorylation and cardiac to L. and MAPKs in cardiac and PubMed Scopus (0) Google Scholar). of O-GlcNAc in cardiomyocytes to to by in cardiomyocytes S. Z. M. J. et cytosolic O-linked and in mouse PubMed Scopus (0) Google Scholar, A.J. et cardiac and Scopus (0) Google and L. R. J. et with O-linked β-N-acetylglucosamine of J. Physiol. PubMed Scopus Google Scholar). these we the of in p38 phosphorylation and found that and of are for p38 phosphorylation in OSMI-1–treated is a of studies O-GlcNAcylation on or or it to in in O-GlcNAc to the pathway to p38 In to the to p38 during OGT we a of p38 that involves Tab1. as a protein that p38 to its H. L. et of mediated by of PubMed Scopus Google Scholar). of has been in many cell cardiac it p38 activity G. J. Y. intracellular of p38 kinase and Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). Here, we found that the of phosphorylation of is a known substrate of OGT S. O. A. O-GlcNAcylation of J. 2012; PubMed Scopus Google Scholar, J.A. G.J. the of the O-linked β-N-acetylglucosamine transferase PubMed Scopus Google and in we that a of is in cardiac it has been that noncanonical p38 is regulation of in cardiac A. Zhang J. J. Y. regulation of noncanonical by in PubMed Scopus Google Scholar). we found that this with which is to that induced by OSMI-1, that the of OGT inhibition of the of p38 from its we that also to in cardiomyocytes. In a inhibition of OGT to a of O-GlcNAc from and which the from the and increased with the to of is that the of for p38 the to A. R. J. L. et and of the of mitogen-activated protein kinase by Biol. 2013; PubMed Scopus Google a O-GlcNAcylation at S. O. A. O-GlcNAcylation of J. 2012; PubMed Scopus Google Scholar). whether O-GlcNAcylation on is for p38 during stress conditions has to and a mouse with a a A mouse for of PubMed Google Scholar). from OGT that p38 in Hart G.W. O-GlcNAcylation of 2012; PubMed Scopus Google Scholar). In the metabolic labeling coupled with and we found that p38 in a to is a of known O-GlcNAcylation on p38 and it is to the or of O-GlcNAc on p38 In the it that O-GlcNAcylation on its phosphorylation by or during it found that a highly conserved the is essential for the of p38 D. C. R. S. M.R. et of mitogen-activated protein kinase is on Cell. Biol. PubMed Scopus (0) Google Scholar). O-GlcNAcylation on the or other the of p38 it is that O-GlcNAcylation by the phosphorylation of p38 during cardiac it during a O-GlcNAcylation and p38 phosphorylation in the heart (11Fülöp N. Zhang Z. Marchase R.B. Chatham J.C. Glucosamine cardioprotection in perfused rat heart associated with increased O-Linked N-acetylglucosamine protein modification and altered p38 activation.Am. J. Physiol. Heart Circ. Physiol. 2007; 292: H2227-H2236Crossref PubMed Scopus (0) Google Scholar). The activity of Erk1/2 in cardiomyocytes and is associated with responses while that of p38 is associated with Y. protein kinase signaling in the in a Rev. PubMed Scopus Google Scholar). In the of OGT inhibition for it that the of Erk1/2 and p38 signaling to the hypertrophic response to with for we found decreased phosphorylation of Erk1/2 and increased phosphorylation of Erk1/2 signaling protein L. signaling is essential for of protein by in PubMed Scopus Google and Erk1/2 the adaptive cardiac Zhang S. A. C. A.J. kinase is for cardiac and survival in response to 2004; PubMed Scopus Google Scholar). in we that Erk1/2 inhibition hypertrophic and Erk1/2 phosphorylation in the of OGT inhibition with a blunted these the expression of a gene for a component of is by Erk1/2 and this response is also during OGT to that of the of p38 in the of is A. A. of the p38 mitogen-activated protein kinase pathway in rat by the and a in cardiac Cell Biol. PubMed Scopus (0) Google and the p38 the hypertrophic p38 signaling in the heart a gene expression increased Anp expression D. A. M. D. H. et al.The in of p38 in cardiac and Natl. Acad. Sci. U. S. A. 2001; PubMed Scopus Google Scholar). we found that the of Anp of is by it is that p38 for the decreased Erk1/2 signaling and to the of Anp expression in the of and OGT Erk1/2 and p38 are to have a in the regulation of the expression of natriuretic S. H. R. O. H. of natriuretic gene p38 mitogen-activated protein kinase and nuclear Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). of OGT to to developmental K.R. et Ogt is essential for J. Physiol. Heart Circ. Physiol. PubMed Scopus Google Scholar, Y. H. Zhang J. J. O-linked β-N-acetylglucosamine transferase an essential in heart development PubMed Scopus Google in growth and In with cardiomyocytes found that OGT inhibition hypertrophic growth induced by Consistent with an growth the expression of Anp and and it cTnT with the the important of OGT in developmental In the O-GlcNAcylation is during the response to its in adaptive et signaling is essential for during J.